Altimmune Inc. (NASDAQ:ALT) finished Wednesday with a subtraction of -$0.06 to close at $2.95, a downside of -1.99 percent. An average of 1,230,900 shares of common stock have been traded in the last five days. There was a fall of -$0.10 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 1,265,980 shares traded, while the 50-day average volume stands at 1,925,720.
ALT stock has decreased by -12.72% in the last month. The company shares reached their 1-month lowest point of $2.89 on 08/09/23. With the stock rallying to its 52-week high on 01/13/23, shares of the company touched a low of $2.95 and a high of $23.49 in 52 weeks. It has reached a new high 3 times so far this year and lost -82.07% or -$13.50 in price. In spite of this, the price is down -87.44% from the 52-week high.
Insider Transactions
ALT stock investors should be aware that Altimmune Inc. (ALT) stock had its last reported insider trading activity 231 days ago on Mar 24. In this transaction, the insider spent $300,268. President and CEO, Garg Vipin K, disposed of 20,000 shares at a price of $20.02 on Aug 31. The insider now owns more than $400,322 worth of shares. Prior to that, President and CEO Garg Vipin K went on to Sale 15,000 shares at $15.06 each on Aug 12. An amount of $225,890 was transacted.
Valuation Metrics
Altimmune Inc. (ALT) stock’s beta is -0.06. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.88.
Financial Health
The quick ratio of Altimmune Inc. for the three months ended March 30 was 11.60, and the current ratio was 11.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30. Its gross profit as reported stood at $87.67 million compared to revenue of $68000.0.
Earnings Surprise
For the three-month period that ended March 30, Altimmune Inc. had $61.04 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$20.07 million in the quarter, while revenues of -$21.66 million were grew 3.19%. The analyst consensus anticipated Altimmune Inc.’s latest quarter earnings to come in at -$0.48 per share, but it turned out to be -$0.4, a 16.70% surprise. For the quarter, EBITDA amounted to -$22.11 million. Shareholders own equity worth $49.29 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Altimmune Inc. (ALT) price momentum. RSI 9-day as of the close on 09 August was 34.68%, suggesting the stock is Neutral, with historical volatility in this time frame at 59.20%.
As of today, ALT’s price is $3.05 -3.28% or -$0.10 from its 5-day moving average. ALT is currently trading -11.14% lower than its 20-day SMA and -73.08% lower than its 100-day SMA. However, the stock’s current price level is -27.87% below the SMA50 and -71.33% below the SMA200.
The stochastic %K and %D were 15.12% and 23.95%, respectively, and the average true range (ATR) was 0.16. With the 14-day stochastic at 11.32% and the average true range at 0.17, the RSI (14) stands at 35.53%. The stock has reached -0.11 on the 9-day MACD Oscillator while the 14-day reading was at -0.09.
Analyst Ratings
Goldman downgraded Altimmune Inc. (NASDAQ: ALT) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for Altimmune Inc. (ALT) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ALT, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 7 others rate it as a “buy”.
What is ALT’s price target for the next 12 months?
Analysts predict a range of price targets between $6.00 and $50.00, with a median target of $25.00. Taking a look at these predictions, the average price target given by analysts for Altimmune Inc. (ALT) stock is $25.13.
